Navigation Links
Weikang Bio-Technology Announces Fiscal 2010 Financial Results
Date:3/22/2011

variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Investor Relations Contact:Paul Kuntz, Senior SpecialistRedChip Companies, Inc.Tel: +1-800-733-2447 x0Email: info@redchip.comWEIKANG BIO-TECHNOLOGY GROUP CO, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME YEARS ENDED DECEMBER 31, 20102009Net sales$
74,554,214$
47,484,188Cost of goods sold29,538,35921,640,326Gross profit45,015,85525,843,862Operating expenses:Selling 3,347,9472,583,202General and administrative 5,452,0141,321,838Research and development2,537,8541,951,000Total operating expenses11,337,8155,856,040Income from operations33,678,04019,987,822Non-operating income (expenses)Interest income82,83813,206Other income481,490973,196Other expenses(2,666)(1,664)Total non-operating income, net 561,662984,738Income before income tax34,239,70220,972,560Income tax9,802,0185,355,758Net income 24,437,68415,616,802Other comprehensive income Foreign currency translation gain 1,680,04021,375Comprehensive Income$
26,117,724$
5,638,177Basic weighted average shares outstanding28,091,28225,375,581Diluted weighted average shares outstanding28,092,743-Basic earnings per share$
.87$
.62Diluted earnings per share$
.87$
-WEIKANG BIO-TECHNOLOGY GROUP CO, INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETSDECEMBER 31 2010 AND 200920102009ASSETS:CURRENT ASSETS:Cash & equivalents $
50,363,812$
,3
'/>"/>

SOURCE Weikang Bio-Technology Group Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Weikang Bio-Technology Issues 2010 and 2011 Fiscal Year Guidance
2. Weikang Bio-Technology to Present at Rodman and Renshaws Annual Global Investment Conference on September 14th 2010
3. Weikang Bio-Technology Reports Second Quarter 2010 Financial Results
4. ICAP Ocean Tomo Announces the Auction of an Improved Compact, Portable Nebulizer Developed and Patented by Tidal Air
5. American Oriental Bioengineering Announces US$20 Million Share Repurchase Program
6. Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACEā„¢ in Nontuberculous Mycobacteria Indication
7. Cord Blood America Announces Affiliate Program to Educate on Value of Umbilical Cord Blood Stem Cell Storage
8. Cytokinetics announces fundamental research in cardiac myosin activation in the journal Science
9. Genesis Biopharma Announces Plans to Develop Active Immunotherapy Platform
10. Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA
11. Seattle BioMed Announces Major Scientific Expansion, New Addition to Leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , ... July 31, 2015 , ... Ralco is honored ... at the Lyon County Fair to be held August 5-9 in Marshall. The Ralco ... their meals come from and how agriculture impacts their daily lives. This unique exhibit ...
(Date:7/30/2015)... ... 2015 , ... The 2015 Market Research Report on the Global Propanol ... global Propanol market with a focus on the Chinese situation. Major companies included in ... ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The ...
(Date:7/30/2015)... 30, 2015   Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients ... reported financial results for the second quarter 2015. ... we remain on track to achieve our commercial and ... Officer of the Company. "Since our last quarterly earnings ...
(Date:7/30/2015)... July 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... received the second $1.0M tranche under a previously ... grant valued at up to $3.0 million to ... surfactant as a potential medical countermeasure to mitigate ... was awarded an initial $1.0 million under this ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... know there are at least five different types of patent ... (1) a search for competitors patents, (2) a clearance search, ... a patent validity search. Each type of search has a ... for competitors patents ,A search for competitors patents is ...
... business. , ,I call it the "humanizing factor" at work. A ... corporate world and the behavior of people in it, but in ... regular people at work (sometimes when you least expect it). , ... examples of the HF in action. , ,A friend goes on ...
... at a Senate appearance earlier this year. Credit: U.S. ... and Human Services Secretary Tommy Thompson announced Wednesday the ... national health information infrastructure in 10 years and bring ... also released a report, prepared by National Health IT ...
Cached Biology Technology:Five ways your company can benefit from patent searches 2Five ways your company can benefit from patent searches 3'Don't work here' job interviews set new Midwest technology trend 2'Don't work here' job interviews set new Midwest technology trend 3'Don't work here' job interviews set new Midwest technology trend 4'Don't work here' job interviews set new Midwest technology trend 5Thompson announces 'Decade of Health Information Technology' 2Thompson announces 'Decade of Health Information Technology' 3Thompson announces 'Decade of Health Information Technology' 4Thompson announces 'Decade of Health Information Technology' 5Thompson announces 'Decade of Health Information Technology' 6
(Date:7/23/2015)... DUBLIN , July 23, 2015 ... the addition of the "Global Outlook of ... their offering. The global biometrics ... both public and commercial applications owing to the ... will witness a transformation that enhances the growth ...
(Date:7/21/2015)... 2015 Passwords have proven futile for ... recent U.S. Office of Personnel Management breach. Biometric ... conundrum, but developers and end-users are concerned about ... dilemma, Biometrics-as-a-Service provider HYPR Corp. announced today the ... third party integration. A video ...
(Date:7/13/2015)... OXFORD, Conn. , Jul. 13, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/188684 for ... NXT-ID achieves another new convenient and secure method ... expands new, innovative payment methods, introduced with its ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... is well known as a highly effective analgesic, its ... drug tolerance, the requirement for increasing doses to maintain ... the June 7 issue of Current Biology, researchers report ... drug cocktail containing morphine along with small doses of ...
... first study to achieve success with gene therapy for ... demonstrating that the formidable scientific challenges that have cast ... with muscular dystrophy can be overcome. Moreover, their results, ... of the National Academy of Sciences (PNAS), indicate that ...
... an accelerated childhood compared to that of modern humans but ... from Ohio State University and the University of Newcastle . ... present in the Neanderthal fossils they examined was comparable to ... And since the rate of tooth growth has become a ...
Cached Biology News:Opiate cocktail may spare cells from morphine's dark side 2No small feat: First ever gene therapy success for muscular dystrophy achieved 2No small feat: First ever gene therapy success for muscular dystrophy achieved 3Neanderthal teeth grew no faster than comparable modern humans' 2Neanderthal teeth grew no faster than comparable modern humans' 3
... is a fluorescent counterstain which ... color. The bright blue fluorescence ... fluorochromes such as rhodamine, Cy3, ... can be used for fluorescent ...
... P450 (CYP450) metabolite postulated to play an ... vasculature. In rat cerebral microvessels, 20-HETE is ... 20-HETE is excreted mainly as the glucuronide ... pg/ml in human urine) is about 10-fold ...
Rabbit polyclonal to Quinaldic Acid ( Abpromise for all tested applications). Antigen: Synthetic peptide Quinaldic Acid conjugated to a protein carrier....
Recommended for supporting the growth of anchorage-dependent cells including human and mouse stromal cells, mesenchymal cells and cell lines....
Biology Products: